The World Molecular Imaging Society (WMIS) has awarded Robert Gillies, PhD, the 2018 Gold Medal Award to honor his lifetime of research in cancer molecular imaging and cancer biology, according to a WMIS press release.
Researchers from the University of California, San Fransisco (UCSF) have demonstrated that gallium 68–labeled prostate-specific membrane antigen–11 PET/MRI may detect higher rates of prostate than multiparametric MRI, according to a study published online Sept. 18 in Radiology.
Using PET imaging in addition to conventional CT imaging for women with locally advanced cervical cancer may identify more detailed malignancies and change treatment plans, according to research published online Sept. 14 in JAMA Network Open.
Roughly 30 U.S. senators and congressional representatives were sought to cosponsor the CT Colonography Screening for Colorectal Cancer Act of 2017—H.R. 1298—at a Capitol Hill briefing on Wednesday, Sept. 12. The meeting was sponsored by the American College of Radiology (ACR) and the Colorectal Cancer Alliance, according to an ACR press release.
Despite national guidelines advising against prostate cancer screening in men 70 or older, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center found that prostate cancer care for this demographic costs Medicare more than $400 million a year, according to a study published Sept. 13 in JAMA Oncology.
Researchers found undergoing MRI scans every six months better detected early breast cancer in young women with a high genetic risk for the disease compared to mammograms.
Authors of recently published Danish-Norwegian research found a steady decline in breast cancer mortality during the 23-year study period. They determined the drop was due to advances in treatment rather than the region’s screening program, according to research published in the International Journal of Cancer.
The American Association for Cancer Research (AACR) released its annual cancer progress report Wednesday, Sept. 12, revealing increasing cases despite progress made in diagnosing and treating various cancers.
MRI has become a central part of diagnosing and managing prostate cancer, but private payer coverage has not kept up with this technological trend, reported authors of a recent Journal of the American College of Radiology study.
Contrast-enhanced ultrasound may be more accurate than CT or MRI in identifying cancerous tumors in the kidneys and could reduce unnecessary biopsies and surgical procedures by half, according to research presented at the 2018 International Contrast Ultrasound Society’s Bubble Conference in Chicago.
Authors of a recent Journal of Nuclear Medicine study have discovered potential for misdiagnosis when relying solely on prostate-specific membrane antigen (PSMA) PET imaging in prostate cancer staging.
